醫療器材銷售協議（2016-2026）

醫療器材產業全球銷售合作展望

本報告 "醫療器材銷售協議趨勢" 對全球醫療器材產業的銷售合作進行了全面分析。報告專為業務拓展、授權和商業策略專業人士設計，深入剖析了企業如何制定銷售協議、協商財務條款以及透過策略合作拓展市場。

這份經過全面修訂和更新的報告分析了2016年至2026年間簽訂的銷售協議，清楚地展示了醫療器材製造商如何與銷售合作夥伴攜手合作，加速新市場開發和商業化進程。

本報告包​​含一份完整的銷售協議清單，該清單已在 "當前協議" 交易和合作資料庫中註冊，並提供指向可用財務條款和線上交易記錄的連結。對於已公開備案的協議，本報告還提供向美國證券交易委員會 (SEC) 提交的底層合約文件的存取權限，從而深入了解銷售合作關係的實際建構方式。

無論您是進行交易結構基準分析、尋找銷售合作夥伴，還是開展商業化戰略盡職調查，本報告都能提供您所需的真實交易數據和合同信息，助您構建更強大的銷售協議。

主要優勢

• 顯著縮短研究時間

無需搜尋多份新聞稿、資料庫和監管文件，即可存取統一的銷售交易資料庫。

• 銷售協議結構基準分析

了解醫療器材公司如何建構其銷售合作關係，包括地域權、商業化責任和營運角色。

• 財務合約分析條款

審查已揭露的付款結構和商業條款，並對類似銷售合作關係的財務結構進行基準分析。

• 查閱實際合約文件

在條件允許的情況下，查閱已向美國證券交易委員會 (SEC) 提交的銷售協議，以深入了解實際合作關係背後的詳細合約條款。

• 識別最活躍的銷售合作夥伴

識別醫療器材產業銷售合作關係中的關鍵參與者，並分析其商業化策略。

• 追蹤產業趨勢

依公司、治療領域和技術領域分析自 2016 年以來的銷售協議趨勢，以了解醫療器材商業化策略的演變。

回報內容

2016 年以來銷售交易趨勢分析

銷售合作關係結構與財務模型概述

基於已揭露資訊的主要銷售協議審查金額

銷售協議中最活躍公司簡介

依公司、治療領域和技術類型分類的交易詳細分析

協議資料庫中已註冊的銷售協議的最新綜合目錄。

線上交易記錄和合約文件連結（如有）

基於實際合約的盡職調查洞察

本報告分析了實際的銷售協議，使用戶能夠評估關鍵的合作條款，例如：

• 地域銷售權
• 合作夥伴之間的商業責任
• 付款結構與商業條款
• 獨家銷售條款
• 供應與銷售義務
• 合約期限和終止條款
• 本報告的重要性
• 銷售合作關係對於醫療器材的全球商業化至關重要。它們使公司能夠擴大市場覆蓋範圍、加速產品上市並獲得區域專業知識。
• 透過結合全面的交易數據、財務基準和實際合約文件，本報告提供了建立更強大的銷售合作關係和更有效地進行談判所需的洞察。

目錄

摘要整理

第一章：引言

第二章：銷售交易趨勢

• 引言
• 銷售協議的定義
• 2016年以來的銷售協議趨勢
  • 依年份劃分的銷售交易
  • 依研發階段劃分的銷售交易
  • 依治療領域劃分的銷售交易
  • 依科技劃分的銷售交易
  • 以最活躍公司劃分的銷售交易
  • 純粹銷售交易的特徵
  • 多組件交易中的銷售特徵
• 協調合作夥伴以確保銷售協議有效運作

第三章 - 銷售協議概述架構

• 引言
• 銷售協議結構
• 作為更廣泛合作協議一部分的銷售權

第四章 - 主要銷售協議

• 引言
• 以價值為排名的頂級銷售交易

第五章 - 最活躍的25家經銷商

• 引言
• 最活躍的25家經銷商
• 交易目錄
• 依公司（AZ）劃分的銷售交易目錄
• 依治療領域劃分的銷售交易目錄
• 以技術類型劃分的銷售交易目錄
• 關於研究公司
• 當前合作夥伴關係
• 當前協議
• 近期合作報告標題

Benchmark Global Distribution Partnerships Across the Medical Device Industry

This latest Distribution Deals in Medical Devices report provides a comprehensive analysis of distribution partnerships across the global medical device sector. Designed for business development, licensing, and commercial strategy professionals, the report delivers detailed insight into how companies structure distribution agreements, negotiate financial terms, and expand market access through strategic partnerships.

Fully revised and updated, the report examines distribution deals announced between 2016 and 2026, providing a clear view of how device manufacturers collaborate with distribution partners to reach new markets and accelerate commercialization.

The report contains a comprehensive listing of distribution deals recorded in the Current Agreements deals and alliances database, including financial terms where available and links to online deal records. Where agreements have been publicly filed, the report also provides access to the underlying contract documents submitted to the SEC, enabling deeper insight into how distribution partnerships are structured in practice.

Whether you are benchmarking deal structures, identifying distribution partners, or performing due diligence on commercialization strategies, this report provides the real-world deal data and contract intelligence needed to structure stronger distribution agreements.

Key Benefits

• Save Significant Research Time

Access a consolidated database of distribution deals instead of searching multiple press releases, databases, and regulatory filings.

• Benchmark Distribution Deal Structures

Understand how medical device companies structure distribution partnerships, including territorial rights, commercialization responsibilities, and operational roles.

• Analyze Financial Deal Terms

Review disclosed payment structures and commercial terms to benchmark the financial structure of comparable distribution partnerships.

• Access Real Contract Documents

Where available, explore SEC-filed distribution agreements, providing insight into the detailed contractual provisions behind real-world partnerships.

• Identify the Most Active Distribution Dealmakers

Discover which companies are leading distribution partnerships across the medical device sector and analyze their commercialization strategies.

• Track Industry Trends

Analyze distribution deal activity since 2016 across companies, therapeutic areas, and technology segments to understand how device commercialization strategies are evolving.

What's Included in the Report

Analysis of distribution dealmaking trends since 2016

Overview of distribution partnership structures and financial models

Review of leading distribution deals by disclosed value

Profiles of the most active distribution dealmakers

Detailed analysis of deals organized by company, therapeutic area, and technology type

A comprehensive directory of distribution deals recorded in the Current Agreements database

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual distribution contracts, the report allows users to evaluate key partnership provisions such as:

• Territorial distribution rights
• Commercial responsibilities between partners
• Payment structures and commercial terms
• Exclusivity provisions
• Supply and commercialization obligations
• Contract duration and termination provisions
• Why This Report Matters
• Distribution partnerships are critical to the global commercialization of medical devices, enabling companies to expand market reach, accelerate product launches, and access regional expertise.
• By combining comprehensive deal data, financial benchmarking, and access to real contract documents, this report provides the intelligence needed to structure stronger distribution partnerships and negotiate more effectively.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deal
• 2.3. Trends in distribution deals since 2016
  • 2.3.1. Distribution dealmaking by year
  • 2.3.2. Distribution dealmaking by phase of development
  • 2.3.3. Distribution dealmaking by therapy area
  • 2.3.4. Distribution dealmaking by technology type
  • 2.3.5. Distribution dealmaking by most active company
  • 2.3.6 Attributes of pure distribution deals
  • 2.3.7 Attributes of distribution in multi-component deals
• 2.4. Aligning partners to make the distribution agreement work

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure
• 3.3 Distribution rights as part of a wider alliance agreement

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements
• Figure 3: Distribution deals signed at each phase of development
• Figure 4: Distribution deals by therapy area
• Figure 5: Distribution deals by technology type
• Figure 6: Top 25 most active distribution dealmakers
• Figure 7: Issues in implementing distribution agreements
• Figure 8: Distribution agreements - what should a contract include?
• Figure 9: Components of the distribution deal structure
• Figure 10: Top distribution deals by value
• Figure 11: Most active distribution dealmakers